Article

Ki67 Assessment By qRT-PCR In OncotypeDx® Breast Recurrent Score®: Low Correlation With Immunohistochemistry Assessment of Ki67 And Prognostic Impact of Ki67 RNA Level of Expression.

2021-07-15

Abstract excerpt

Breast cancers expressing high levels of Ki67 are associated with poor outcomes. Oncotype DX ® test was designed for ER+/HER2- early-stage breast cancers to help adjuvant chemotherapy decision by providing a Recurrent Score ® (RS ® ). RS ® measures the expression of 21 specific genes from tumor tissue, including Ki67 . The primary aim of this study was to assess the agreement between Ki67 RNA obtained with Oncotyp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 616a0e1d-a4c3-547a-96c5-78624631c1aa
DOI: 10.21203/rs.3.rs-677106/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ki67 Assessment By qRT-PCR In OncotypeDx® Breast Recurrent Score®: Low Correlation With Immunohistochemistry Assessment of Ki67 And Prognostic Impact of Ki67 RNA Level of Expression.DOI 10.21203/rs.3.rs-677106/v1Read

Ki67 Assessment by qRT-PCR in OncotypeDx ® Breast Recurrent Score®: Low Correlation With IHC Assessment of ki67 and Prognostic Impact of ki67 RNA Level of Expression.Semantic proximity Read

Evaluating the Association of Ki 67 with Oncotype DX Recurrence Score in Early-Stage ER Positive/HER2 Negative Breast CancerSemantic proximity Read

Favorable Locoregional Control in Clinically Node- Negative Hormone-receptor Positive Breast Cancer With Low 21-gene Recurrence Scores: a Single Institutional Study With 10-year Follow-upSemantic proximity Read

The Role of Ki-67 in HR+/HER2- Breast Cancer: a Real-world Study of 956 PatientsSemantic proximity Read

Associations Between the 21-Gene Oncotype DX Recurrence Score, Ki67, and Race in Early Breast Cancer: An Analysis of the National Cancer DatabaseSemantic proximity Read

Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimensSemantic proximity Read

Ki-67 as a prognostic marker according to breast cancer molecular subtypeSemantic proximity Read

Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCRSemantic proximity Read

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sectionsSemantic proximity Read

Determination of Hormone Receptors, Human Epidermal Growth Factor Receptor 2 and Ki67 Status in Invasive Breast Carcinoma: A Concordance Study between Immunohistochemistry, Fluorescence in Situ Hybridization, and GeneXpert® Breast Cancer STRAT4 AssaySemantic proximity Read

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.Semantic proximity Read

Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast CancerSemantic proximity Read